These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36063051)

  • 1. Identification of genetic mechanisms for tissue-specific genetic effects based on CRISPR screens.
    Dvir E; Shohat S; Flint J; Shifman S
    Genetics; 2022 Nov; 222(3):. PubMed ID: 36063051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions.
    Munoz DM; Cassiani PJ; Li L; Billy E; Korn JM; Jones MD; Golji J; Ruddy DA; Yu K; McAllister G; DeWeck A; Abramowski D; Wan J; Shirley MD; Neshat SY; Rakiec D; de Beaumont R; Weber O; Kauffmann A; McDonald ER; Keen N; Hofmann F; Sellers WR; Schmelzle T; Stegmeier F; Schlabach MR
    Cancer Discov; 2016 Aug; 6(8):900-13. PubMed ID: 27260157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Amplifications Cause False Positives in CRISPR Screens.
    Sheel A; Xue W
    Cancer Discov; 2016 Aug; 6(8):824-6. PubMed ID: 27485003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovering false negatives in CRISPR fitness screens with JLOE.
    Dede M; Hart T
    Nucleic Acids Res; 2023 Feb; 51(4):1637-1651. PubMed ID: 36727483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Essential Genes Using Sequential CRISPR and siRNA Screens.
    DeHart L; Yockey OP; Bakke J
    Methods Mol Biol; 2022; 2377():89-107. PubMed ID: 34709612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PICKLES v3: the updated database of pooled in vitro CRISPR knockout library essentiality screens.
    Novak LC; Chou J; Colic M; Bristow CA; Hart T
    Nucleic Acids Res; 2023 Jan; 51(D1):D1117-D1121. PubMed ID: 36350677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DrugThatGene: integrative analysis to streamline the identification of druggable genes, pathways and protein complexes from CRISPR screens.
    Canver MC; Bauer DE; Maeda T; Pinello L
    Bioinformatics; 2019 Jun; 35(11):1981-1984. PubMed ID: 30395160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Discovery of Cancer Immunotherapy Targets by Intercellular CRISPR Screens.
    Yim S; Hwang W; Han N; Lee D
    Front Immunol; 2022; 13():884561. PubMed ID: 35651625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EasyCatch, a convenient, sensitive and specific CRISPR detection system for cancer gene mutations.
    Liu Y; Chen Y; Dang L; Liu Y; Huang S; Wu S; Ma P; Jiang H; Li Y; Pan Y; Wei Y; Ma X; Liu M; Ji Q; Chi T; Huang X; Wang X; Zhou F
    Mol Cancer; 2021 Dec; 20(1):157. PubMed ID: 34856977
    [No Abstract]   [Full Text] [Related]  

  • 12. A pan-CRISPR analysis of mammalian cell specificity identifies ultra-compact sgRNA subsets for genome-scale experiments.
    Zhao B; Rao Y; Leighow S; O'Brien EP; Gilbert L; Pritchard JR
    Nat Commun; 2022 Feb; 13(1):625. PubMed ID: 35110534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor immunology CRISPR screening: present, past, and future.
    Dong MB; Tang K; Zhou X; Zhou JJ; Chen S
    Trends Cancer; 2022 Mar; 8(3):210-225. PubMed ID: 34920978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of CRISPR systems in respiratory health: Entering a new 'red pen' era in genome editing.
    Moses C; Kaur P
    Respirology; 2019 Jul; 24(7):628-637. PubMed ID: 30883991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo CRISPR screening for novel noncoding RNA functional targets in glioblastoma models.
    Attenello FJ; Tsung K; Bishara I; Loh YE; Chen TC
    J Neurosci Res; 2021 Sep; 99(9):2029-2045. PubMed ID: 33969526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas gene therapy.
    Zhang B
    J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer CRISPR Screens In Vivo.
    Chow RD; Chen S
    Trends Cancer; 2018 May; 4(5):349-358. PubMed ID: 29709259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR Screens in Toxicology Research: An Overview.
    Sobh A; Russo M; Vulpe CD
    Curr Protoc; 2021 May; 1(5):e136. PubMed ID: 34043288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Comparison of CRISPR and shRNA Screens to Identify Essential Genes Using a Graph-Based Unsupervised Learning Model.
    Ding Y; Denomy C; Freywald A; Pan Y; Vizeacoumar FJ; Vizeacoumar FS; Wu FX
    Cells; 2024 Oct; 13(19):. PubMed ID: 39404416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research advances on the development and application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein system].
    Tan JJ; Peng YZ; Huang GT
    Zhonghua Shao Shang Za Zhi; 2021 Jul; 37(7):681-687. PubMed ID: 34304411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.